psilocybinPapers
Indexed under psilocybin as a PubMed major topic
- papers
- 122
Newest first
1 to 50 of 122Every paper here, unless its row says otherwiseIndexed under psilocybin in PubMed
Comparing Cannabis Use Motivations and Dependence Across Regular Cannabis Users Who Have or Have Not Recently Used Psilocybin.
Cannabis and cannabinoid research2026PMID 38885938
Psilocybin for major depressive disorder: An updated systematic review and meta-analysis of randomized clinical trials.
Journal of psychopharmacology (Oxford, England)2026PMID 39480198
Shame, Guilt and Psychedelic Experience: Results from a Prospective, Longitudinal Survey of Real-World Psilocybin Use.
Journal of psychoactive drugs2026PMID 39921237
Temporal dynamics in neuroimaging as correlates of therapeutic response to psilocybin in major depressive disorder: A systematic review and critical appraisal.
Journal of affective disorders2026PMID 40962065
Cognitive and subjective effects of psilocybin microdosing: Results from two double-blind placebo-controlled longitudinal trials.
Neuropharmacology2026PMID 41110634
Microdosing psilocybin and its effect on creativity: Lessons learned from three double-blind placebo controlled longitudinal trials.
Neuropharmacology2026PMID 41187880
Divergent effects of ketamine and psilocybin on EEG power spectral density in a mismatch negativity paradigm.
Psychopharmacology2026PMID 41191045
Psilocybin-assisted therapy for individuals with palliative care needs: A systematic review of safety and efficacy.
Palliative medicine2026PMID 41410211
Breaking the chains of depression: A systematic review and meta-analysis of psilocybin therapy.
Journal of affective disorders2026PMID 41419063
Comparing single- and repeat-dose psilocybin with active placebo for migraine prevention in an exploratory randomized controlled clinical trial.
Headache2026PMID 41459830
The effects of psilocybin on time perception in humans: A comparative analysis of subjective and objective measures.
Journal of psychopharmacology (Oxford, England)2026PMID 41479142
The effects of psilocybin on psychological distress in cancer patients: a systematic review and meta-analysis.
BMC psychology2026PMID 41484687
Pharmacological Management of Anxiety in End-of-Life Care: A Systematic Review of Benzodiazepines, Opioids, and Psilocybin.
Human psychopharmacology2026PMID 41502021
Methodological moderators of psilocybin-assisted therapy in depression: A systematic review and meta-analysis.
Neuroscience and biobehavioral reviews2026PMID 41587629
Effects of psilocybin on personality, psychiatric symptoms, and values: Exploring mediating effects of the acute psychedelic experience.
Journal of psychopharmacology (Oxford, England)2026PMID 41588876
Psilocybin-induced alterations in EEG power, connectivity and network dynamics in healthy subjects: Correlations with subjective experience and implications for therapeutic applications.
Progress in neuro-psychopharmacology & biological psychiatry2026PMID 41611012
Spatiotemporal mapping of brain organisation following the administration of 2C-B and psilocybin.
Molecular psychiatry2026PMID 41634136
Therapeutic effects of psilocybin in major depressive disorder: a systematic review and meta-analysis exploring dose effects.
European archives of psychiatry and clinical neuroscience2026PMID 41677823
Examining the effects of psilocybin-assisted psychotherapy on anhedonia in treatment-resistant depression.
Journal of affective disorders2026PMID 41690631
Effects of LSD, DMT and psilocybin on cognitive and psychological functions: A systematic review of the literature.
Journal of psychopharmacology (Oxford, England)2026PMID 41699449
Participant Experiences of Therapeutic Touch in Psilocybin-Assisted Therapy.
Brain and behavior2026PMID 41699875
Psilocybin or Nicotine Patch for Smoking Cessation: A Pilot Randomized Clinical Trial.
JAMA network open2026PMID 41805956
A randomized clinical trial of repeated doses of psilocybin for the treatment of obsessive-compulsive disorder.
Journal of psychopharmacology (Oxford, England)2026PMID 41825921
Efficacy and Safety of Psilocybin in Treatment-Resistant Major Depression: The EPISODE Randomized Clinical Trial.
JAMA psychiatry2026PMID 41848690
Psilocybin-assisted therapy for major depressive disorder: Perspective from meta-analysis.
Journal of affective disorders2026PMID 41876058
The role of therapeutic alliance in psilocybin treatment for treatment-resistant depression: A post hoc path analysis.
Journal of affective disorders2026PMID 41881122
Evaluation of a facilitator training program in a randomized controlled trial of psilocybin treatment for depression.
BMC medical education2026PMID 41952163
Acute dose-dependent effects of 4-bromo-2,5-dimethoxyphenethylamine (2C-B) compared with 3,4-methylenedioxymethamphetamine (MDMA) and psilocybin in a double-blind, placebo-controlled study in healthy participants.
Neuropsychopharmacology2026PMID 42049943
Psilocybin in the Treatment of Cocaine Use Disorder: A Randomized Clinical Trial.
JAMA network open2026PMID 42096204
Efficacy and Safety of a Single Dose of Psilocybin for Chronic Suicidal Ideation: An Open-Label Trial.
The Journal of clinical psychiatry2026PMID 42138588
Short-Term and Late-Term Effects of Psilocybin on Symptoms in Major Depression: A Randomized Clinical Trial.
JAMA network open2026PMID 42138922
Epigenome-wide association study of psilocybin-induced methylome changes in alcohol use disorder.
Translational psychiatry2026PMID 42192100
Blinding integrity in psychedelic research: Evidence from a comparative randomized controlled trial of psilocybin, MDMA, and methylphenidate in healthy volunteers.
European neuropsychopharmacology2026PMID 42208423
Modeled Long-Term Effects of Psilocybin on Dynamic Activity and Effective Connectivity of Fronto-Striatal-Thalamic Circuits.
Human brain mapping2026PMID 42381187
CSF galanin and noradrenaline downregulation by psilocybin therapy in major depressive disorder.
Neuropsychopharmacology2026PMID 42414566
Psilocybin-assisted therapy for treatment-resistant major depressive disorder in a public healthcare setting: a randomized controlled trial.
Nature medicine2026PMID 42562964
Safety and Mental Health Outcomes of Oregon State-Regulated Psilocybin Services.
JAMA network open2026PMID 42616497
Apomorphine and psilocybin to improve recovery from coma in the intensive care unit: protocol for a prospective, open-label, dose-escalation study.
BMJ open2026PMID 42772877
Multilevel Mechanisms and Clinical Efficacy of Psilocybin in Depression Treatment: A Systematic Review.
International journal of molecular sciences2026PMID 42794483
Clinical Evidence on Psilocybin and Its Representation in Media Reporting: A Systematic Review.
JAMA network open2026PMID 42900476
Safety and efficacy of psilocybin-assisted therapy for alcohol use disorder: Open-label extension of a phase II randomized controlled trial.
Drug and alcohol dependence2026PMID 42913354
Psilocybin therapy for treatment resistant depression: prediction of clinical outcome by natural language processing.
Psychopharmacology2025PMID 37606733
Psilocybin and chronic neuropathic pain: a systematic review.
Regional anesthesia and pain medicine2025PMID 39106989
Pharmacokinetics of Psilocybin, a Tryptamine Alkaloid in Magic Mushroom (Psilocybe cubensis): A Systematic Review.
Journal of psychoactive drugs2025PMID 39257234
Comparing psilocybin to metformin as neuroprotective agents against Parkinson's dementia: A systematic review of evidence and efficacy.
Progress in neuro-psychopharmacology & biological psychiatry2025PMID 39357666
Examining differences in the effects and contexts of naturalistic psilocybin use for White participants vs. Participants of Color: A longitudinal online survey study.
Journal of affective disorders2025PMID 39447981
Randomized Controlled Trials of Psilocybin-Assisted Therapy in the Treatment of Major Depressive Disorder: Systematic Review and Meta-Analysis.
Acta psychiatrica Scandinavica2025PMID 39627679
The safety of psilocybin-assisted psychotherapy: A systematic review.
The Australian and New Zealand journal of psychiatry2025PMID 39670342
Psilocybin increases emotional empathy in patients with major depression.
Molecular psychiatry2025PMID 39695323
Multidimensional Personality Changes Following Psilocybin-Assisted Therapy in Patients With Alcohol Use Disorder: Results From a Double-Blind, Placebo-Controlled Clinical Trial.
The American journal of psychiatry2025PMID 39741446